Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Posted 4/7/2022

WASHINGTON, DC ? Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA?s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge in counterfeit pills that are mass-produced by criminal drug networks in labs, deceptively marketed as legitimate prescription pills, and are killing unsuspecting Americans at an unprecedented rate.

These counterfeit pills have been seized by DEA in every U.S. state in unprecedented quantities. More than 9.5 million counterfeit pills were seized so far this year, which is more than the last two years combined. DEA laboratory testing reveals a dramatic rise in the number of counterfeit pills containing at least two milligrams of fentanyl, which is considered a lethal dose. A deadly dose of fentanyl is small enough to fit on the tip of a pencil.  To read the full announcement click here.

Back to all news

Sponsor Spotlight


RxGov by Tyler Technologies
RxGov is a leading Prescription Monitoring Platform (PMP) that improves access to clinical data pertinent to a patient's medication history and the risk factors associated with substance use disorder through the capture, analysis, proactive monitoring, and open sharing of a state's prescription dispense details.

The system is one of the most interoperable, integrated and intuitive on the market. It also includes complete oversight and compliance with the state's current PDMP system, including statewide mandates. RxGov allows the PDMP administrator unprecedented access to insightful data sets, such as query history and compliance reports at all levels: state, region, organization, and individual prescriber. Freely accessible data, enhanced by useful visualization tools, is central to RxGov.

To learn more about RxGov and how the platform can help state governments fight the opioid crisis, email rxgov@egov.com or download our one pager.

All Sponsors